This established medication ... research directions in the field of headache medicine. Medical organizations periodically update their recommendations for migraine treatment based on evolving ...

Migraines last anywhere between four and 72 hours to days, depending on the intensity of symptoms. Learn how long acute and ...

Migraine is a neurological disorder and it differs from garden-variety headaches. People are likely to suffer from migraine if they have had at least five headache attacks in their lives, each lasting ...

Atogepant, a new oral prescription drug, shows promise in preventing migraines by targeting CGRP receptors, reducing migraine ...

New research is challenging assumptions that eating certain foods "cause" migraine attacks. So, what (and how) should people ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in ...

Significantly more patients with acute migraine who received a 10 L per minute dose of a transnasal cooling device had pain freedom at 2 hours vs. those who received sham, according to research ...

Migraine pain usually happens one-sided whereas regular headache happens on both sides of the head, the forehead, or the ...

Menstrual migraine affects more than half of people with both periods and migraine. Find out what you can do to manage this ...

Behavioral interventions may reduce migraine frequency and improve migraine-related disability in adult and pediatric patients.

But even if you’re a headache veteran who's able to tough out even the most debilitating episodes, there are a few critical ...

Discover the latest breakthroughs in migraine treatment for 2025, including CGRP inhibitors, AI-powered personalized plans, wearable neuroregulators, and mRNA-based therapies. Learn expert ...